Maggot therapy for calciphylaxis wound debridement complicated by bleeding

Calciphylaxis is a rare disease with significant morbidity and mortality. Reported 1-year mortality is up to 80%, with sepsis as the leading cause of death.1 Although most cases occur in end-stage renal disease patients on dialysis, nonuremic cases also occur. Maggot therapy for wound debridement in calciphylaxis has been reported, but the literature is limited.